AFRM heads into the week after a strong month with an unusual dynamic: the analyst community is moving more constructively just as short sellers trim exposure, yet options traders are edging more defensive — leaving the stock's near-term setup genuinely mixed.
The Street's direction of travel has shifted meaningfully since the last note. The split picture described a week ago — Morgan Stanley stepping to the sidelines while bulls lifted targets — has since resolved in the bulls' favour. On July 8 alone, JP Morgan raised its target to $90 from $80 while maintaining Overweight, and Barclays initiated with an Overweight at $97. Wells Fargo also raised to $96. The day before, TD Cowen made the most aggressive move of the cluster, lifting its target to $117 from $90. That follows Citigroup's push to $115 on July 1. The mean consensus target now sits at $87.04, modestly above the current $83.62 close — but the range from Morgan Stanley's $79 floor to TD Cowen's $117 ceiling shows the Street agrees AFRM has momentum without agreeing on how much room is left. The bull case — expanding merchant partnerships, geographic reach into Canada and the UK, and the Affirm Bank optionality — is well-rehearsed. Bears point to funding concentration risk, competitive pressure in payments, and the reliance on both on- and off-balance sheet financing in an uncertain credit cycle.
Short positioning tells the quieter side of the story. At 6.6% of the free float, short interest is real but has been gradually retreating — down roughly 6% over the past month as the stock climbed 31%. That unwinding has happened without any squeeze pressure in the lending market: borrow availability is extremely loose at 562%, meaning there are more than five shares available for every one currently borrowed. Cost to borrow is just 0.47%, well below any level that would constrain new short-sellers from entering. The short score sits at 48.5, near the middle of its recent range with no directional conviction from either side. Taken together, the lending market picture is one of orderly short covering rather than a forced unwind.
Options have been turning more cautious as the stock moves higher. The put/call ratio has climbed to 1.08, roughly 1.7 standard deviations above its 20-day average of 1.05 — elevated relative to recent history, though still well below its 52-week high of 1.23. The drift higher in the PCR over the past fortnight suggests some participants are hedging the gains from a strong June rather than pressing new longs. That caution is consistent with the factor score picture: EPS momentum over 30 days ranks in the 70th percentile, a genuine positive, but EPS surprise ranks at just the 22nd percentile, and the short score rank sits at 24 — meaning most of the universe has shorts in a tighter spot than AFRM.
On the institutional side, Capital Research added over 5.4 million shares as of June 30 and now holds 14.2% of the company, a notable move. Fidelity added 3.2 million shares and JP Morgan Asset Management added 2.8 million in the same period — three major institutions building simultaneously into a 31% monthly run. That degree of institutional accumulation behind a rally adds some credibility to the move. Insider activity is less supportive: the COO sold 100,000 shares at $80.04 on June 26, a $8 million disposal, followed by smaller routine sales on July 1. Those are not alarming on their own, but they run against the institutional buying current.
Affirm reports next on August 24. The most recent earnings print in May produced a modest one-day decline of around 2.4%, with the stock recovering slightly over the following five days — a pattern consistent with a market that is not using earnings as a clearing event in either direction. With the stock now 31% higher over one month and four firms raising targets on a single day, the August print will be less about whether the BNPL thesis holds and more about whether the implied growth rate in those $115-$117 price targets is achievable in the near-term numbers.
See the live data behind this article on ORTEX.
Open AFRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
